Nintedanib versus placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: TRICC-C trial—Final results from the randomized phase II trial of the AIO. This is an ASCO ...
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center In 658 patients with advanced GI cancers who underwent both ...
Transnasal endoscopy has emerged as a versatile approach for diagnostic and therapeutic evaluation of the upper gastrointestinal tract. By advancing an ultrathin endoscope through the nasal passage ...
Quality of life (QOL) is an important outcome after treatment for upper gastrointestinal tract cancer but few studies report good accrual and subsequent attrition is usually high. This study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results